One example of the use of both cellular and in silico models to further our understanding of the impact rare variants have on AD is that of the well-studied TREM2 coding changes which have been subject of a number of in vitro, in vivo and in silico models [89–91]. This evidence concerns the gene TREM2 and Alzheimer disease.